Society of Hematologic Oncology

Free SOHO Membership: www.sohoonline.org

 

All Older AML Patients and Younger Patients with Adverse Biology Should Receive HMA/Venetoclax Instead of 3+7/Standard Induction

1,014 views
October 17, 2019
Comments 0
Login to view comments. Click here to Login